Stage and Survival in Breast Cancer Patients in Screened and Non-screened Danish and Swedish Populations

References

• Engeland A, Haldorsen T, Dickman PW, et al. Relative survival of cancer patients—a comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49–59.
   PubMed Web of Science ®Google Scholar
• National Board of Health, Copenhagen Denmark. The Danish National Cancer Plan, II, epidemiologi. National Board of Health, Copenhagen, Denmark; 2000.
   Google Scholar
• Tulinius H, Storm HH, Pukkala E, Andersen A, Ericsson J. Cancer in the Nordic countries, 1981–86. A joint publication of the five Nordic Cancer Registries. APMIS 1992; (Suppl 31): 1–194.
   Google Scholar
• Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS 1994; (Suppl 49): 1–161.
   Google Scholar
• Engholm G, Christensen N, Storm HH. Improvement, but still a lower cancer survival in Denmark than in the other Nordic countries. Int J Cancer 2002; (Suppl 13): 89.
   Google Scholar
• UICC, TNM classification of malignant tumours. 5th ed. 1997.
   Google Scholar
• Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 1993; 32: 641–6.
   Google Scholar
• Andersen KW, Mouridsen HT. Danish Breast Cancer Co-operative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 627–47.
   Google Scholar
• Sant M, Capocaccia R, Coleman MP, et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 1659–67.
   PubMed Web of Science ®Google Scholar
• Jensen AR, Game JP, Engholm G, Storm HH, Overgaard J. Breast cancer: a tale of two cities-comparison between two neighbouring countries: impact of mammography, early detec-tion and axillary surgery. Int J Cancer 2002; (Suppl 13): 107.
   Google Scholar
• Christensen L, Engholm G, Tange UB, et al. Can differences in classical prognostic parameters explain the 10% survival difference between Danish and Swedish women with breast cancer. Int J Cancer 2002; (Suppl 13): 107–8.
   Google Scholar
• Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954–8.
   Google Scholar
• Buiatti E, Barchielli A, Bartolacci S, et al. Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy. Cancer Causes Control 2002; 13: 65–71.
   PubMedGoogle Scholar
• Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829–32.
   Google Scholar
• Tubiana M, Koscielny S. Natural history of human breast cancer: recent data and clinical implications. Breast Cancer Res Treat 1991; 18: 125–40.
   PubMed Web of Science ®Google Scholar
• Tubiana M, Koscielny S. The rationale for early diagnosis of cancer-the example of breast cancer. Acta Oncol 1999; 38: 295–303.
   PubMedGoogle Scholar
• Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol 1995; 13: 1144–51.
   PubMed Web of Science ®Google Scholar
• Koscielny S, Tubiana M, Le MG, et al. Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 1984; 49: 709–15.
   PubMed Web of Science ®Google Scholar
• Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. Bt Med J 1988; 297: 943–8.
   PubMed Web of Science ®Google Scholar
• Paci E, Giorgi D, Bianchi S, et al. Assessment of the early impact of the population-based breast cancer screening pro-gramme in Florence (Italy) using mortality and surrogate measures. Eur J Cancer 2002; 38: 568–73.
   PubMedGoogle Scholar
• Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet 2000; 355: 1822.
   Google Scholar
• Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–77.
   PubMed Web of Science ®Google Scholar
• Barnes DM, Hanby AM. Oestrogen and progesterone recep-tors in breast cancer: past, present and future. Histopathology 2001; 38: 271–4.
   PubMedGoogle Scholar
• Andreasen AH, Andersen KW, Madsen M, Mouridsen H, Olesen KP, Lynge E. Regional trends in breast cancer incidence and mortality in Denmark prior to mammographic screening. Br J Cancer 1994; 70: 133–7.
   PubMed Web of Science ®Google Scholar